Melanoma Care Team
The Melanoma Care Team at the University of Virginia is devoted to providing the most advanced treatments for patients with melanoma, as well as cutaneous T-cell lymphoma, intraocular cancer, Kaposi's sarcoma, Merkel cell carcinoma, and skin cancer. The Melanoma Team is comprised of a combination of specialists, including surgeons, medical oncologists, and pathologists, who meet weekly to discuss effectiveness of current treatments and progress in development of trials in order to provide patients with the newest and most promising treatments customized to their individual needs. The services of social workers, psychologists, and patient support groups are also available. This team seeks to develop treatments that improve quality and length of life by translating laboratory research into clinical trials.
The Melanoma Team is a world leader in the development and testing of vaccines for the treatment of melanoma and prevention of its recurrence. Various innovative clinical trials testing these vaccines are available through the Human Immune Therapy Center, whose mission is to offer hope to cancer patients by making available the newest types of immune therapy, creating new knowledge about how to help the immune system kill cancer, and providing national leadership in testing new therapies and bringing them into standard practice.
The Melanoma Team is part of the University of Virginia Cancer Center, which is a highly ranked National Cancer Institute designated Cancer Center.